Bo - so Teva paid $3.5bn
Question: What Income did Auspex have @ 31 /12/2014
Answer : $Nil
Question : What was Auspex cash position at 31/12/2014 ?
Answer : US$29.7m cash
Question: What is Auspex major asset
Answer : In 2014, Auspex reported positive results from its Phase 3 clinical trial for SD-809 in Huntington's disease, with plans to submit a New Drug Application (NDA) for this indication by mid-2015.
Point to note is that Pharma is after blockbuster applications..and there lies the opportunity in Mesoblast.
My view only and please DYOR.
GLTAH - 2015
Trading high volume, page-147
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |